more attention focused on urinary incontinence
August 2001
You'll see more attention focused on urinary incontinence.
This is a big problem. More than 15 million people in North America suffer from bladder problems...only about 10% seek help.
The attention is partly fueled by interest in new extended-release versions of Ditropan (oxybutynin) and Detrol (tolterodine).
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote